Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Bisphosphonates

Additional information

Pharmaceutical Benefits Scheme listings for drugs mentioned in this guideline for the use of bisphosphonates for advanced breast cancer are available at www.pbs.gov.au

Recommendations for use of bisphosphonates for advanced breast cancer
was prepared and produced by:

National Breast and Ovarian Cancer Centre*
Level 1 Suite 103/355 Crown Street Surry Hills NSW 2010
Tel: +61 2 9357 9400 Fax: +61 2 9357 9477 Freecall 1800 624 973
Website: www.nbocc.org.au

Cancer Australia 2011

This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part
might be reproduced by any process without prior written permission from National Breast
and Ovarian Cancer Centre*. Requests and enquiries concerning reproduction and rights should
be addressed to the Corporate Communications Manager, National Breast and Ovarian
Cancer Centre*.

Recommended citation
National Breast and Ovarian Cancer Centre*. Recommendations for use of bisphosphonates for advanced breast cancer. National Breast and Ovarian Cancer Centre*, Surry Hills, NSW, 2011.

Disclaimer
National Breast and Ovarian Cancer Centre* does not accept any liability for any injury, loss or
damage incurred by use of or reliance on the information. National Breast and Ovarian Cancer
Centre* develops material based on the best available evidence, however it cannot guarantee
and assumes no legal liability or responsibility for the currency or completeness
of the information.

National Breast and Ovarian Cancer Centre* is funded by the Australian Government
Department of Health and Ageing.

* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Published using CeCC Docbook Manager